ESMO press release – Genitourinary cancers

[ESMO 2018 Press Release] Date: 21 Oct 2018 Topic: Genitourinary cancers MUNICH, Germany РA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improves progression-free survival (PFS) in...